Choose your font:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 English 
 Français 
 Português 

[Valid RSS] RSS
bar

Database - Alliance francophone pour l'accouchement respecté (AFAR)

Description of this bibliographical database (AFAR website)
YouTube channel (tutorial)

https://afar.info/id=859

Created on : 27 Jul 2004
Modified on : 27 Dec 2007

 Modify this record
Do not follow this link unless you know an editor’s password!


Share: Facebook logo   Tweeter logo   Hard

Bibliographical entry (without author) :

Cost Utility of Prenatal Diagnosis and the Risk-Based Threshold. Obstet Gynecol Surv. 2004 Jul;59(7):497-498.

Author(s) :

Harris RA, Washington AE, Nease RF Jr, Kuppermann M.

Year of publication :

2004

URL(s) :

http://www.obgynsurvey.com/pt/re/obgynsurv/abstrac…

Résumé (français)  :

Abstract (English)  :

Prenatal testing in the form of amniocentesis or chorionic villus sampling is commonly recommended for women 35 years of age or older as well as those found by screening to be at high risk of having an infant with a chromosomal abnormality such as Down syndrome. When these guidelines were developed in the 1970s, age 35 was the approximate time at which amniocentesis was cost-beneficial. The authors report the findings from a cost-utility analysis of amniocentesis and chorionic villus sampling versus no invasive testing. Data were taken from randomized trials, case registries, and a utility assessment of 534 pregnant women ranging in age from 16 to 47 years. The decision model that was used addresses the decision to carry out diagnostic testing based on age-adjusted risk or revised risk estimates after screening. At age 35 years, the incremental cost-utility ratio for amniocentesis was approximately $12,600 per quality-adjusted life years (QALY). The cost-utility ratio remained below $15,000 per QALY regardless of maternal age. This figure did not change despite wide variations in probability estimates. Less than $50,000 per QALY gained is within the generally accepted range for routine healthcare interventions. The results also were independent of the risk of a Down syndrome birth. For any particular woman, the cost-utility ratio depended on her preferences for reassurance about the chromosomal status of her fetus and, to a lesser degree, for miscarriage. When a probabilistic sensitivity analysis was carried out by running 50,000 simulations and changing all variables in the model except for patient utilities, the cost utility of testing was less than $30,000 per QALY gained in more than 99.98% of the simulations. This cost-utility analysis does not support the current practice of limiting amniocentesis and chorionic villus sampling to women aged 35 and older and those who are at high risk of bearing a chromosomally abnormal fetus. The investigators believe that prenatal diagnostic testing should be offered to all pregnant women. It is most important to take individual preferences into account when making decisions about prenatal testing.

Sumário (português)  :

Comments :

Argument (français) :

Le coût de l’amniocentèse ne justifie pas de la limiter aux femmes agées de plus de 35 ans ou à haut risque.

Argument (English):

Argumento (português):

Keywords :

➡ amniocentesis ; screening ; miscarriage ; maternal age ; trisomy

Author of this record :

Cécile Loup — 27 Jul 2004

Discussion (display only in English)
 
➡ Only identified users



 I have read the guidelines of discussions and I accept all terms (read guidelines)

barre

New expert query --- New simple query

Creating new record --- Importing records

User management --- Dump database --- Contact

bar

This database is managed by Alliance francophone pour l'accouchement respecté (AFAR, https://afar.info)
affiliated with Collectif interassociatif autour de la naissance (CIANE, http://ciane.net).
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) contributing to this database if you have a minimum training in documentation
(2) or financially supporting AFAR (see below)
(3) or joining the AFAR (or another society affiliated with CIANE).
Sign in or create an account to follow changes or become an editor.
Contact afar.association(arobase)gmail.com for more information.

Valid CSS! Valid HTML!
Donating to AFAR (click “Faire un don”) will help us to maintain and develop sites and public
databases towards the support of parents and caregivers’ informed decisions with respect to childbirth